Monath TP - Search Results

1

Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.

Monath TP, Soike K, Levenbook I, Zhang ZX, Arroyo J, Delagrave S, Myers G, Barrett AD, Shope RE, Ratterree M, Chambers TJ, Guirakhoo F. Monath TP, et al. Vaccine. 1999 Apr 9;17(15-16):1869-82. doi: 10.1016/s0264-410x(98)00487-3. Vaccine. 1999. PMID: 10217584

2

Analysis of ChimeriVax Japanese Encephalitis Virus envelope for T-cell epitopes and comparison to circulating strain sequences.

De Groot AS, Martin W, Moise L, Guirakhoo F, Monath T. De Groot AS, et al. Vaccine. 2007 Nov 19;25(47):8077-84. doi: 10.1016/j.vaccine.2007.09.026. Epub 2007 Sep 29. Vaccine. 2007. PMID: 17942198

3

Heterogeneous nature of the genome of the ARILVAX yellow fever 17D vaccine revealed by consensus sequencing.

Pugachev KV, Ocran SW, Guirakhoo F, Furby D, Monath TP. Pugachev KV, et al. Among authors: monath tp. Vaccine. 2002 Jan 15;20(7-8):996-9. doi: 10.1016/s0264-410x(01)00439-x. Vaccine. 2002. PMID: 11803058

4

Clinical proof of principle for ChimeriVax: recombinant live, attenuated vaccines against flavivirus infections.

Monath TP, McCarthy K, Bedford P, Johnson CT, Nichols R, Yoksan S, Marchesani R, Knauber M, Wells KH, Arroyo J, Guirakhoo F. Monath TP, et al. Vaccine. 2002 Jan 15;20(7-8):1004-18. doi: 10.1016/s0264-410x(01)00457-1. Vaccine. 2002. PMID: 11803060 Clinical Trial.

5

Protection against Japanese encephalitis virus strains representing four genotypes by passive transfer of sera raised against ChimeriVax-JE experimental vaccine.

Beasley DW, Li L, Suderman MT, Guirakhoo F, Trent DW, Monath TP, Shope RE, Barrett AD. Beasley DW, et al. Among authors: monath tp. Vaccine. 2004 Sep 9;22(27-28):3722-6. doi: 10.1016/j.vaccine.2004.03.027. Vaccine. 2004. PMID: 15315852

6

ChimeriVax-West Nile virus live-attenuated vaccine: preclinical evaluation of safety, immunogenicity, and efficacy.

Arroyo J, Miller C, Catalan J, Myers GA, Ratterree MS, Trent DW, Monath TP. Arroyo J, et al. Among authors: monath tp. J Virol. 2004 Nov;78(22):12497-507. doi: 10.1128/JVI.78.22.12497-12507.2004. J Virol. 2004. PMID: 15507637 Free PMC article.

7

Construction and biological characterization of artificial recombinants between a wild type flavivirus (Kunjin) and a live chimeric flavivirus vaccine (ChimeriVax-JE).

Pugachev KV, Schwaiger J, Brown N, Zhang ZX, Catalan J, Mitchell FS, Ocran SW, Rumyantsev AA, Khromykh AA, Monath TP, Guirakhoo F. Pugachev KV, et al. Among authors: monath tp. Vaccine. 2007 Sep 17;25(37-38):6661-71. doi: 10.1016/j.vaccine.2007.07.016. Epub 2007 Jul 27. Vaccine. 2007. PMID: 17693000

Although the theoretical concern of genetic recombination has been raised related to the use of live attenuated flavivirus vaccines [Seligman, Gould, Lancet 2004;363:2073-5], it has little foundation [e.g., Monath TP, Kanesa-Thasan N, Guirakhoo F, Pugachev K, Almond …

Although the theoretical concern of genetic recombination has been raised related to the use of live attenuated flavivirus vaccines [Seligma …

8

Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.

Guirakhoo F, Zhang ZX, Chambers TJ, Delagrave S, Arroyo J, Barrett AD, Monath TP. Guirakhoo F, et al. Among authors: monath tp. Virology. 1999 May 10;257(2):363-72. doi: 10.1006/viro.1999.9695. Virology. 1999. PMID: 10329547 Free article.

9

Immunization of rhesus monkeys with a mucosal prime, parenteral boost strategy protects against infection with Helicobacter pylori.

Lee CK, Soike K, Giannasca P, Hill J, Weltzin R, Kleanthous H, Blanchard J, Monath TP. Lee CK, et al. Among authors: monath tp. Vaccine. 1999 Aug 6;17(23-24):3072-82. doi: 10.1016/s0264-410x(99)00144-9. Vaccine. 1999. PMID: 10462242

10

Chimeric yellow fever virus 17D-Japanese encephalitis virus vaccine: dose-response effectiveness and extended safety testing in rhesus monkeys.

Monath TP, Levenbook I, Soike K, Zhang ZX, Ratterree M, Draper K, Barrett AD, Nichols R, Weltzin R, Arroyo J, Guirakhoo F. Monath TP, et al. J Virol. 2000 Feb;74(4):1742-51. doi: 10.1128/jvi.74.4.1742-1751.2000. J Virol. 2000. PMID: 10644345 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

332 results

Search Page